These data imply that geriatric participants with Severe-Moderate Cognitive Impairment indicated a higher level of HbA1c, cystatin C, and SIRT1 compared to those of the other two groups, regardless of their genders. This evidence concerns the gene CST3 and Cognitive impairment.